Kronos Bio, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price
Kronos Bio, Inc. had Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price of $8.90 per share as of 2024-12-31, per its 10-K filed 2025-03-18.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice · last filed 2025-03-18
- 2024-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price $8.90.
- 2023-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price $10.66.
- 2022-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price $11.94.
- 2021-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price $10.51.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price |
|---|---|
| 2024-12-31 | $8.90 10-K · filed 2025-03-18 |
| 2023-12-31 | $10.66 10-K · filed 2024-03-21 |
| 2022-12-31 | $11.94 10-K · filed 2023-03-15 |
| 2021-12-31 | $10.51 10-K · filed 2022-02-24 |
| 2020-12-31 | $2.37 10-K · filed 2021-03-23 |
| 2020-09-30 | $1.33 10-Q · filed 2020-11-18 |